Zenith Capital Financials

Zenith Capital Stock Summary

Zenith Capital competes with ProMIS Neurosciences, Fennec Pharmaceuticals, Cellectis, Covalon Technologies, and Eliem Therapeutics. Zenith Capital Corp., a biotechnology investment company, engages in the development of bromodomain inhibitors for the treatment of cancer and other disorders with unmet medical needs. The company was incorporated in 2013 and is headquartered in Calgary, Canada. Zenith Cap operates under Biotechnology classification in the United States and is traded on OTC Exchange.

Zenith Capital Key Financial Ratios

There are many critical financial ratios that Zenith Capital's investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Zenith Capital Corp reports annually and quarterly.

Zenith Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Zenith Capital's current stock value. Our valuation model uses many indicators to compare Zenith Capital value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Zenith Capital competition to find correlations between indicators driving Zenith Capital's intrinsic value. More Info.Zenith Capital Corp is rated first in return on asset category among its peers. It is rated below average in current valuation category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Zenith Capital's earnings, one of the primary drivers of an investment's value.

Zenith Capital Corp Systematic Risk

Along with financial statement analysis, the daily predictive indicators of Zenith Capital help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Zenith Capital Corp. We use our internally-developed statistical techniques to arrive at the intrinsic value of Zenith Capital Corp based on widely used predictive technical indicators. In general, we focus on analyzing Zenith Pink Sheet price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Zenith Capital's daily price indicators and compare them against related drivers.

When running Zenith Capital's price analysis, check to measure Zenith Capital's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Zenith Capital is operating at the current time. Most of Zenith Capital's value examination focuses on studying past and present price action to predict the probability of Zenith Capital's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Zenith Capital's price. Additionally, you may evaluate how the addition of Zenith Capital to your portfolios can decrease your overall portfolio volatility.